HARBORING

作品数：84被引量：159H指数：6
导出分析报告
相关领域：医药卫生农业科学更多>>
相关作者：张景昱叶梁宋艳茹王小桐更多>>
相关机构：中国科学院植物研究所南京军区南京总医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划国家高技术研究发展计划福建省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=World Journal of Clinical Casesx
共 条 记 录，以下是1-6
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Intra-abdominal ectopic bronchogenic cyst with a mucinous neoplasm harboring a GNAS mutation: A case report被引量：1
《World Journal of Clinical Cases》2022年第24期8709-8717,共9页Takashi Murakami Hiroaki Shimizu Kazuto Yamazaki Hiroyuki Nojima Akihiro Usui Chihiro Kosugi KiyohikoShuto Shuntaro Obi Takahisa Sato Masato Yamazaki Keiji Koda 
BACKGROUND Bronchogenic cysts are congenital cysts caused by abnormal sprouting from the ventral foregut during fetal life.They usually occur in the mediastinum or lung,but there are very rare cases of ectopic broncho...
关键词：Congenital hereditary and neonatal diseases and abnormalities Ectopic bronchogenic cyst Abdominal neoplasms GNAS mutation Carcinoembryonic antigen Case report 
Response to dacomitinib in advanced non-small-cell lung cancer harboring the rare delE709_T710insD mutation:A case report
《World Journal of Clinical Cases》2022年第17期5916-5922,共7页Fei Xu Meng-Ling Xia Hui-Yun Pan Jiong-Wei Pan Yi-Hong Shen 
BACKGROUND Tyrosine kinase inhibitors(TKI)have been the standard first-line therapy for advanced non-small cell lung cancer(NSCLC)of epidermal growth factor receptor(EGFR)sensitive mutations.Uncommon EGFR mutations ar...
关键词：Next-generation sequencing DelE709_T710insD Non-small-cell lung cancer Dacomitinib Uncommon EGFR mutation Case report 
Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody:A case report
《World Journal of Clinical Cases》2022年第8期2497-2503,共7页Fei-Fei Yan Qi Jiang Bin Ru Xiao-Jie Fei Jian Ruan Xiao-Chen Zhang 
Supported by the Zhejiang Medical Association;No. 2018ZYC-A18
BACKGROUND Immune checkpoint inhibitors(ICIs)targeting the programmed death(PD)-1 pathway have substantially changed the clinical management of metastatic urothelial carcinoma(m UC);however,the response rate remains l...
关键词：Urothelial carcinoma Bladder cancer ERBB Programmed death Sindilimab Case report 
Successful treatment of refractory lung adenocarcinoma harboring a germline BRCA2 mutation with olaparib:A case report
《World Journal of Clinical Cases》2021年第25期7498-7503,共6页Li Zhang Jing Wang Ling-Zhi Cui Kai Wang Ming-Ming Yuan Rong-Rong Chen Li-Jiao Zhang 
BACKGROUND In recent years,targeted therapy and immunotherapy have become important treatment strategies for patients with non-small cell lung cancer(NSCLC).However,the clinical evidence for successful off-label use o...
关键词：Non-small cell lung cancer Next-generation sequencing BRCA2 gene Poly(adenosine diphosphate-ribose)polymerase inhibitor Case report 
Primary pancreatic paraganglioma harboring lymph node metastasis: A case report被引量：2
《World Journal of Clinical Cases》2021年第27期8071-8081,共11页Cui-Nan Jiang Xiao Cheng Jing Shan Mei Yang Yu-Qing Xiao 
BACKGROUND Primary pancreatic paragangliomas are extremely rare tumors.Limited by the diagnostic efficacy of histopathological examination,their malignant behavior is thought to be associated with local invasion or me...
关键词：PARAGANGLIOMA PANCREAS Lymph node metastasis Distal pancreatectomy Case report 
Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib:A case report
《World Journal of Clinical Cases》2020年第17期3841-3846,共6页Shu-Sen Zhai Hui Yu Tian-Tian Gu Yan-Xia Li Yan Lei Hai-Yan Zhang Tong-Huan Zhen Yun-Ge Gao 
BACKGROUND Epidermal growth factor receptor(EGFR)tyrosine-kinase inhibitors are widely used for the treatment of non-small-cell lung cancer with EGFR mutations.However,patients with rare,even compound EGFR mutations h...
关键词：Icotinib hydrochloride Epidermal growth factor receptor L858R/V834L Nonsmall cell lung cancer Stable disease Case report 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部